Genentech

RITUXAN

Manufacturer:

Genentech

Rituxan HCPCS:

J9312

HCPCS Code Descriptor:

Injection, rituximab, 10 mg

Category:

J Code

Rituxan NDCs:

50242-0051-21, 50242-0053-06

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Rituxan:

RITUXAN is an Oncology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J9312 is aligned to the drug RITUXAN.

ACCESS PRICING AND MORE BY REGISTERING

J9312 Added Date:

January 1, 2019

J9312 Effective Date:

January 1, 2019

J9312 Termination Date:

HCPCS Active

Rituxan billing and coding information can be found through Genentech at the link below:
Rituxan patient assistance information can be found through Genentech at the URL: https://www.gene.com/patients/patient-foundation
RITUXAN prescribing information can be found at the link below:
Information regarding RITUXAN’s side effects can be found at MedlinePlus